| Literature DB >> 32573695 |
Elena Shanina1,2, Eike Siebs3,4,5, Hengxi Zhang1,2, Daniel Varón Silva1,2, Ines Joachim3,4,5, Alexander Titz3,4,5, Christoph Rademacher1,2.
Abstract
The carbohydrate-binding protein LecA (PA-IL) from Pseudomonas aeruginosa plays an important role in the formation of biofilms in chronic infections. Development of inhibitors to disrupt LecA-mediated biofilms is desired but it is limited to carbohydrate-based ligands. Moreover, discovery of drug-like ligands for LecA is challenging because of its weak affinities. Therefore, we established a protein-observed 19F (PrOF) nuclear magnetic resonance (NMR) to probe ligand binding to LecA. LecA was labeled with 5-fluoroindole to incorporate 5-fluorotryptophanes and the resonances were assigned by site-directed mutagenesis. This incorporation did not disrupt LecA preference for natural ligands, Ca2+ and d-galactose. Following NMR perturbation of W42, which is located in the carbohydrate-binding region of LecA, allowed to monitor binding of low-affinity ligands such as N-acetyl d-galactosamine (d-GalNAc, Kd = 780 ± 97 μM). Moreover, PrOF NMR titration with glycomimetic of LecA p-nitrophenyl β-d-galactoside (pNPGal, Kd = 54 ± 6 μM) demonstrated a 6-fold improved binding of d-Gal proving this approach to be valuable for ligand design in future drug discovery campaigns that aim to generate inhibitors of LecA.Entities:
Keywords: LecA; NMR; drug discovery; lectin
Mesh:
Substances:
Year: 2021 PMID: 32573695 PMCID: PMC7874386 DOI: 10.1093/glycob/cwaa057
Source DB: PubMed Journal: Glycobiology ISSN: 0959-6658 Impact factor: 4.313